EAM

Erste Asset Management Portfolio holdings

AUM $11.9B
1-Year Return 22.95%
This Quarter Return
+6.55%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
AUM
$8.35B
AUM Growth
+$800M
Cap. Flow
+$530M
Cap. Flow %
6.34%
Top 10 Hldgs %
25.64%
Holding
915
New
37
Increased
219
Reduced
115
Closed
35

Sector Composition

1 Technology 35.05%
2 Healthcare 16.36%
3 Financials 12.4%
4 Consumer Discretionary 9%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LGND icon
451
Ligand Pharmaceuticals
LGND
$3.23B
$419K 0.01%
4,300
GLPG icon
452
Galapagos
GLPG
$2.21B
$410K ﹤0.01%
14,000
SWTX
453
DELISTED
SpringWorks Therapeutics
SWTX
$397K ﹤0.01%
12,300
CINF icon
454
Cincinnati Financial
CINF
$24B
$380K ﹤0.01%
2,800
+500
+22% +$67.8K
RDN icon
455
Radian Group
RDN
$4.77B
$369K ﹤0.01%
10,600
+1,800
+20% +$62.7K
PFG icon
456
Principal Financial Group
PFG
$17.8B
$362K ﹤0.01%
4,200
-700
-14% -$60.3K
ZLAB icon
457
Zai Lab
ZLAB
$3.49B
$357K ﹤0.01%
15,100
UNFI icon
458
United Natural Foods
UNFI
$1.74B
$354K ﹤0.01%
21,144
BALL icon
459
Ball Corp
BALL
$13.9B
$337K ﹤0.01%
+5,000
New +$337K
TPL icon
460
Texas Pacific Land
TPL
$21B
$337K ﹤0.01%
380
-170
-31% -$151K
NTAP icon
461
NetApp
NTAP
$24.2B
$336K ﹤0.01%
2,700
+700
+35% +$87.1K
IOVA icon
462
Iovance Biotherapeutics
IOVA
$861M
$327K ﹤0.01%
34,000
BCYC
463
Bicycle Therapeutics
BCYC
$496M
$325K ﹤0.01%
14,000
BCRX icon
464
BioCryst Pharmaceuticals
BCRX
$1.72B
$305K ﹤0.01%
40,000
PICK icon
465
iShares MSCI Global Metals & Mining Producers ETF
PICK
$838M
$296K ﹤0.01%
6,850
GL icon
466
Globe Life
GL
$11.4B
$282K ﹤0.01%
2,700
-500
-16% -$52.2K
SBAC icon
467
SBA Communications
SBAC
$20.5B
$265K ﹤0.01%
1,100
ARE icon
468
Alexandria Real Estate Equities
ARE
$14.6B
$249K ﹤0.01%
2,100
AFG icon
469
American Financial Group
AFG
$11.5B
$243K ﹤0.01%
1,800
GRFS icon
470
Grifois
GRFS
$6.88B
$242K ﹤0.01%
27,056
MRVI icon
471
Maravai LifeSciences
MRVI
$353M
$239K ﹤0.01%
28,400
JBLU icon
472
JetBlue
JBLU
$1.85B
$234K ﹤0.01%
36,460
-36,000
-50% -$231K
RXRX icon
473
Recursion Pharmaceuticals
RXRX
$2.02B
$234K ﹤0.01%
33,500
VIR icon
474
Vir Biotechnology
VIR
$721M
$217K ﹤0.01%
28,800
KURA icon
475
Kura Oncology
KURA
$707M
$215K ﹤0.01%
11,000